Correvio's heart drug fails to win FDA panel backing

news.yahoo.com
1 min read
fairly difficult
The panel voted 11-2 against approval of the drug, Brinavess, citing serious safety risks. Brinavess, currently available in 41 countries including the Euro...
(Reuters) - Independent experts to the U.S. Food and Drug Administration on Tuesday voted against Correvio Pharma Corp's drug to correct irregular rhythm in the upper chambers of the heart in adult patients.

The panel voted 11-2 against approval of the drug, Brinavess, citing serious safety risks.

Brinavess, currently available in…
Reuters
Read full article